• Rolled over price concessions for July 2025

    The following price concessions granted in June 2025 have rolled over to July 2025: Drug Pack size June 2025 price concession Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Nizatidine 150mg capsules 30 £21.69 Sulfasalazine 500mg tablets 112 £6.61 Please note any rolled

    Read more
  • EPS rolls out across Wales

    NHS England has announced that the rollout of the Electronic Prescription Service (EPS) is well underway across primary care in Wales. As of June 2025: All seven pharmacy system suppliers operating in Wales now support EPS. The majority of pharmacies in Wales are now able to receive electronic prescriptions. EPS utilisation is estimated to be

    Read more
  • June 2025 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (01/07/2025) confirmed the following final list of price concessions for June 2025.  Drug Pack size Price concession Ascorbic acid 100mg tablets 28 £26.89 Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Mercaptopurine 50mg tablets

    Read more
  • Rollout of prescription status info in the NHS App continues

    The National Patient Prescription Tracking Service (NPPTS) enables patients to access and track their prescriptions online through the NHS App or their NHS account (by logging in on the NHS website). NPPTS is a feature of the Electronic Prescription Service (EPS) that utilises a combination of Spine and Pharmacy IT supplier systems’ information to provide

    Read more
  • Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd

    MHRA Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets (Erythrocin 250 Tablets) Amdipharm UK Ltd Drug alert number: EL(25)A/32 Date issued: 01 July 2025 Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL. The superseded PIL used

    Read more
  • June 2025 Price Concessions 3rd Update

    The Department of Health and Social Care (DHSC) has today (30/06/2025) confirmed the following list of price concessions for June 2025: Drug Pack size Price concession Erythromycin 250mg gastro-resistant tablets 28 £3.74 Esomeprazole 20mg gastro-resistant capsules 28 £2.99 Esomeprazole 40mg gastro-resistant capsules 28 £2.17 Ivabradine 2.5mg tablets 56 £26.22 Mefenamic acid 250mg tablets 28 £6.10 Progesterone

    Read more
  • Overwhelming public support for Pharmacy First service despite medicine supply issues

    New research commissioned by Healthwatch England shows that public satisfaction with pharmacy services remains high a year after the NHS launched Pharmacy First, despite persistent medicine shortages that continue to disrupt patient care. In a poll of over 7,000 adults in England, 86% of those who sought help for common conditions reported a positive experience,

    Read more
  • July 2025 Category M prices announced

    The Drug Tariff Category M pricelist for July 2025 has been published on the NHS Business Services Authority (NHSBSA) website. Based on our analysis of the Category M price list for July 2025, Community Pharmacy England estimates there will be an overall reduction in reimbursement on like-for-like Category M medicines of approximately -£35m per quarter,

    Read more
  • Service fee advances

    Service fee advances

    Community Pharmacy England recently announced that consultation fees for the Hypertension Case-Finding Service (HCFS) and the Pharmacy Contraception Service (PCS) are to be included in the advance payments issued to pharmacy owners by the NHS Business Services Authority. The first service fee advance was received on 12 May (for activity completed in April 2025) and

    Read more
  • MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd)

    MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) Drug Alert Number: EL(25)A/31 Date issued: 30 June 2025 Wockhardt UK Limited is recalling the above batch as a precautionary measure following the identification of a dissolution failure during stability testing. DMRC reference number:DMRC-35980389 Marketing Authorisation Holder:Wockhardt UK Ltd Medicine Details Product name: Tamoxifen 20mg

    Read more